- Home
- REAL vs AUTL Comparison
REAL vs AUTL Comparison
Compare REAL & AUTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REAL
- AUTL
- Stock Information
- Founded
- REAL 2011
- AUTL 2014
- Country
- REAL United States
- AUTL United Kingdom
- Employees
- REAL N/A
- AUTL N/A
- Industry
- REAL Other Specialty Stores
- AUTL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- REAL Consumer Discretionary
- AUTL Health Care
- Exchange
- REAL Nasdaq
- AUTL Nasdaq
- Market Cap
- REAL 718.6M
- AUTL 590.8M
- IPO Year
- REAL 2019
- AUTL 2018
- Fundamental
- Price
- REAL $5.50
- AUTL $1.89
- Analyst Decision
- REAL Buy
- AUTL Strong Buy
- Analyst Count
- REAL 6
- AUTL 3
- Target Price
- REAL $8.00
- AUTL $10.20
- AVG Volume (30 Days)
- REAL 3.8M
- AUTL 1.3M
- Earning Date
- REAL 05-06-2025
- AUTL 05-13-2025
- Dividend Yield
- REAL N/A
- AUTL N/A
- EPS Growth
- REAL N/A
- AUTL N/A
- EPS
- REAL N/A
- AUTL N/A
- Revenue
- REAL $600,484,000.00
- AUTL $10,091,000.00
- Revenue This Year
- REAL $11.62
- AUTL $660.48
- Revenue Next Year
- REAL $10.06
- AUTL $193.67
- P/E Ratio
- REAL N/A
- AUTL N/A
- Revenue Growth
- REAL 9.32
- AUTL 82.71
- 52 Week Low
- REAL $2.24
- AUTL $1.68
- 52 Week High
- REAL $11.38
- AUTL $6.63
- Technical
- Relative Strength Index (RSI)
- REAL 35.11
- AUTL 43.80
- Support Level
- REAL $4.90
- AUTL $1.84
- Resistance Level
- REAL $5.96
- AUTL $2.08
- Average True Range (ATR)
- REAL 0.50
- AUTL 0.12
- MACD
- REAL -0.04
- AUTL 0.02
- Stochastic Oscillator
- REAL 26.84
- AUTL 46.67
About REAL The RealReal Inc.
The RealReal is the largest pure-play luxury resale platform in the us, generating $1.7 billion in 2023 gross merchandise volume and addressing a niche (personal luxury resale) that had previously been serviced by inefficient upscale boutiques and local pawn shops. The company generates revenue via consignment and first-party sales on its online marketplace, and through a small volume of direct sales. With a hands-on approach that actively sources inventory and authenticates every item on its platform, The RealReal is able to justify much higher take rates than peers, working out to roughly 34% of net merchandise value, which excludes returns, cancellations, and first-party sales.
About AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.